Toprol XL (Metoprolol Succinate) Extended-Release Tablets
Toprol XL is a prescription extended-release oral beta-1 blocker containing metoprolol succinate. It is used in adults for hypertension, angina and heart failure with reduced ejection fraction, with once-daily dosing.
- Active ingredients
- Metoprolol
- Manufacturer
- AstraZeneca
- Dosage forms
- extended-release tablet
- Available dosages
- 25mg, 50mg, 100mg, 200mg
- Category
- Cardiovascular Medications
What is it?
Toprol XL is the brand name for the extended-release succinate salt of metoprolol, marketed by AstraZeneca. It is supplied as oral extended-release tablets at 25mg, 50mg, 100mg and 200mg, and is dispensed only on prescription. Toprol XL is the form of metoprolol approved for heart failure with reduced ejection fraction in major trials, where it has been shown to reduce mortality and hospitalisations.
Active ingredients
Each tablet contains metoprolol succinate as the sole active ingredient at strengths providing the equivalent of 25mg, 50mg, 100mg or 200mg of metoprolol. Metoprolol is a cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, contractility and atrioventricular conduction velocity.
Forms and dosages
Toprol XL is administered orally once daily, with or without food. According to the prescribing information, the usual starting dose is 25mg or 50mg once daily for hypertension and angina, with titration based on response. In heart failure with reduced ejection fraction, dosing typically starts at 12.5mg to 25mg once daily, with gradual up-titration every two weeks under medical supervision to a target dose of 200mg once daily, when tolerated. Tablets must not be crushed.
Indications
Toprol XL is approved in adults for the treatment of hypertension, chronic stable angina pectoris and stable, symptomatic heart failure with reduced ejection fraction (NYHA class II to IV), in addition to standard therapy. According to international guidelines, metoprolol succinate is one of the recommended evidence-based beta-blockers in heart failure with reduced ejection fraction, alongside bisoprolol and carvedilol.
How it works
Metoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate, contractility and atrioventricular conduction velocity, and lowering myocardial oxygen demand. At higher doses it can also block beta-2 receptors. The extended-release formulation provides a relatively flat 24-hour plasma profile, supporting once-daily dosing. Long-term use in heart failure with reduced ejection fraction is associated with reverse remodelling and improved survival.
Frequently asked questions
What is the difference between Toprol XL and metoprolol tartrate? ▾
Toprol XL is the extended-release succinate salt taken once daily, while metoprolol tartrate is the immediate-release salt typically taken two to three times daily. Toprol XL is the form approved for heart failure with reduced ejection fraction in pivotal trials. According to the prescribing information, the two are not interchangeable on a milligram-for-milligram basis without dose adjustment, and switching should be supervised by the prescriber.
Can Toprol XL be used in asthma or COPD? ▾
Metoprolol is cardioselective for beta-1 receptors, but selectivity diminishes at higher doses, and beta-2 blockade can trigger bronchospasm in susceptible patients. According to international guidelines, beta-blockers are not absolutely contraindicated in mild to moderate asthma or COPD when there is a strong cardiovascular indication, but careful titration with cardioselective agents and specialist supervision are recommended. Severe or unstable asthma remains a contraindication.
Why should Toprol XL not be stopped abruptly? ▾
Abrupt discontinuation of Toprol XL can cause rebound increases in heart rate, blood pressure and myocardial oxygen demand, with rare cases of myocardial infarction or arrhythmia, particularly in patients with ischaemic heart disease. According to the prescribing information, gradual tapering over one to two weeks is recommended, supervised by the prescriber. This is particularly important after long-term therapy or in elderly patients.
Does Toprol XL improve heart failure survival? ▾
Yes. Large randomised trials have shown that metoprolol succinate reduces mortality, hospitalisations and the rate of progression in heart failure with reduced ejection fraction. According to international guidelines, metoprolol succinate is one of the recommended evidence-based beta-blockers in this setting, with bisoprolol and carvedilol as alternatives. The dose is up-titrated gradually under medical supervision.
What are the main contraindications for Toprol XL? ▾
Toprol XL is contraindicated in known hypersensitivity, in second or third-degree atrioventricular block without a pacemaker, in cardiogenic shock, in severe bradycardia and severe peripheral arterial disease, and in decompensated heart failure. Caution is required in unstable asthma, severe hepatic impairment, diabetes (where it can mask hypoglycaemia symptoms), and pregnancy. According to the prescribing information, the medical history must be reviewed by a clinician before any prescription.
Related medications
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.